Trial · NCT00093496
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Patients Who Experience a Confirmed Response According to Modified RECIST Criteria. | Cohort 1 (No Prior Gemcitabine Exposure) | Confirmed Partial Response (PR) | 0.071 | proportion of participants | |
| Proportion of Patients Who Experience a Confirmed Response According to Modified RECIST Criteria. | Cohort 2 (Prior Gemcitabine Exposure) | Confirmed Partial Response (PR) | 0 | proportion of participants | |
| Proportion of Patients Who Experience a Confirmed Response According to Modified RECIST Criteria. | Cohort 1 (No Prior Gemcitabine Exposure) | Confirmed Complete Response (CR) | 0 | proportion of participants | |
| Proportion of Patients Who Experience a Confirmed Response According to Modified RECIST Criteria. | Cohort 2 (Prior Gemcitabine Exposure) | Confirmed Complete Response (CR) | 0 | proportion of participants | |
| Times to Progression | Cohort 1 (No Prior Gemcitabine Exposure) | 1.6 | 95% Confidence Interval 1.2 to 3.5 | months | |
| Times to Progression | Cohort 2 (Prior Gemcitabine Exposure) | 2.7 | 95% Confidence Interval 1.3 to 5.1 | months | |
| Overall Survival | Cohort 1 (No Prior Gemcitabine Exposure) | 18.3 | 95% Confidence Interval 6.2 to NA | months | |
| Overall Survival | Cohort 2 (Prior Gemcitabine Exposure) | 11.5 | 95% Confidence Interval 4.0 to 13.7 | months | |
| Toxicity | Cohort 1 (No Prior Gemcitabine Exposure) | Grade 3 | 9 | events | |
| Toxicity | Cohort 2 (Prior Gemcitabine Exposure) | Grade 3 | 7 | events | |
| Toxicity | Cohort 1 (No Prior Gemcitabine Exposure) | Grade 4 or Higher | 0 | events | |
| Toxicity | Cohort 2 (Prior Gemcitabine Exposure) | Grade 4 or Higher | 0 | events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00093496/results